Astrid Schäfer

Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers.

Part of Evolva Holding SA, Abunda Nutrition, Inc. discovers, develops and commercializes next-generation food ingredients and product solutions. The company is based in San Francisco, CA. Abunda Nutrition was acquired by Evolva Holding SA on July 08, 2011 for $56.98 million.

Lonza AG engages in the research in as well as development, production, and distribution of chemical products and materials. The firm also carries out investment and lending transactions. The company was founded on December 7, 1897 and is headquartered in Visp, Switzerland.

PolyPeptide Laboratories Holding (PPL) AB manufactures commercial therapeutic peptides. The firm offers polypeptide, custom peptide synthesis, peptide synthesis, and generic peptide. The company was founded in 1996 and is headquartered in Malmo, Sweden.

Founded in 1873, Siegfried AG is a chemical product manufacturing company. The company is based in Zofingen, Switzerland and is a part of Siegfried Holding AG.

Deccan Fine Chemicals (India) Pvt Ltd. engages in custom manufacturing of active ingredients and advanced intermediates for agro chemical, fine, and specialty chemical sectors. Its products are used in business areas such as crop protection, and pharmaceutical and animal health. The company was founded in 2008 is headquartered in Hyderabad, India.

Neuroth Hörcenter AG engages in the sale and distribution of hearing aids and hearing protection products. It specializes in hearing aid and child acoustics, hearing protection, and medical technology. The company was founded by Paula Neuroth on December 13, 1907 and is headquartered in Zug, Switzerland.

Sivantos GmbH engages in the development, production, and distribution of hearing aids. It also offers accessories, adjustment software, and smartphone apps. The company was founded by Werner von Siemens in 1878 and is headquartered in Erlangen, Germany.

University Children's Hospital Basel provides a large-scale biomedical database and research resource called UK Biobank. The private company is based in Basel, Switzerland. The database contains in-depth genetic and health information from half a million UK participants, which is regularly augmented with additional data. Approved researchers and scientists can access the database to undertake vital research into the most common and life-threatening diseases. UK Biobank has enabled several scientific discoveries that improve human health.

Lindt & Sprungli SA manufactures and sells chocolates and candies. It offers cacao beans and confectionery products. The company was founded on May 16, 1967 and is headquartered in Paris, France.

Ghirardelli Chocolate Co. manufactures and markets chocolate products. Its products include chocolate bars, shakes, seasonal treats, baking chips, and cocoa powder. The company was founded by Domingo Ghirardelli in 1852 and is headquartered in San Leandro, CA

Chocoladefabriken Lindt & Sprüngli (Schweiz) AG engages in the production and distribution of chocolate products. It offers its products under the brands Bâtons, CHOCOLETTI, CONNAISSEURS, DIVA, EXCELLENCE, GRAND PLAISIR, HAUCHDÜNN, Lindor, and Lindt Mini Pralinés. The company was founded on June 10, 1994 and is headquartered in Kilchberg, Switzerland.

Part of Ernst & Young Global Ltd., Ernst & Young AG is a Swiss company that provides accounting services. The company is based in Zurich, Switzerland.

Part of Bayer AG, Bayer Consumer Care AG is a Swiss company that manufactures and distributes pharmaceutical products. The company is based in Basel, Switzerland.

Veraison Capital AG (VERAISON) is an independent Swiss asset management firm which was founded in 2014 by Elad Ben-Am, Yann Wermeille, Christopher Detweiler, Valentin Chapero Rueda and Gregor Greber. Based in Zurich, the firm manages the VERAISON engagement fund, aiming to identify undervalued and misunderstood companies in which they seek to enhance value and improve shareholder returns through engagement.

Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow.

Founded in 1966, Synthomer (UK) Ltd. is a subsidiary of Synthomer Plc. The company is based in Harlow, UK. Synthomer (UK specializes in creating emissions-reducing formulations that are used to make a wide range of products that are essential to modern life.

Arch Chemicals Ltd. engages in the manufacture of inorganic basic chemicals. Its products are mainly used in the swimming pool for body treatment. The company was founded on February 24, 1978 and is headquartered in Castleford, the United Kingdom.

Sweet Harvest Foods Co. manufactures sweet food products. The company was founded in 1923 and is headquartered in Cannon Falls, MN.